Guideline Current Fleischner Society 2017
Fleischner Society 2017 Guidelines for Management of Incidentally Detected Pulmonary Nodules
Size- and morphology-based follow-up recommendations for incidentally detected pulmonary nodules in adults ≥35 years, excluding lung cancer screening and immunocompromised or oncologic patients.
Updated Jul 5, 2026
Applies to
- Adults ≥ 35 years
- Incidentally detected pulmonary nodules on CT
- Solid and subsolid nodules
Classification
- Risk group Low-risk
- Risk group High-risk
Exclusions
- Patients < 35 years
- Lung cancer screening (use Lung-RADS)
- Known primary or metastatic malignancy
- Immunocompromised patients
Interactive
Decision tree
Enter a finding to compute a recommendation without leaving the page.
Recommendation builder
Choose nodule type and patient risk. Multiplicity is informational; the engine matches by nodule type and size.
Evidence
References
FAQ
Frequently asked
Does this guideline apply to oncology patients?
No — patients with known malignancy fall outside the scope unless the guideline states otherwise. Follow oncologic surveillance protocols instead.
